(Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | (Q3)Jan 31, 2023 | (Q2)Oct 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -238.87%-325.31K | -199.91%-1.17M | -546.66%-1.51M | -103.69%-8.26K | -69.48%114.3K | 0.97%234.25K | 118.95%1.17M | 186.60%337.38K | -21.18%223.75K | 161.87%374.55K |
Net income from continuing operations | 72.62%-52.51K | 27.27%-212.01K | -226.35%-165.23K | 618.99%964.53K | -432.71%-819.55K | -132.24%-191.77K | 97.02%-291.5K | 103.13%130.76K | 96.75%-185.85K | 11.07%-153.85K |
Operating gains losses | -534.40%-344.93K | -313.75%-256.26K | 730.87%1.44M | -5,846.18%-1.18M | -367.43%-596.03K | -23.78%79.4K | -96.89%119.88K | -106.02%-227.62K | 134.79%20.46K | 105.05%222.88K |
Depreciation and amortization | -93.75%3.58K | -34.69%202.68K | 95.84%131.94K | -83.75%10.21K | -97.45%3.19K | 4.15%57.34K | 40.18%310.35K | 300.99%67.37K | -36.51%62.85K | 77.63%125.07K |
Asset impairment expenditure | ---- | --1.23M | ---914.94K | --914.94K | ---- | ---- | --0 | --0 | --0 | ---- |
Unrealized gains and losses of investment securities | ---- | ---1.21M | ---109.58K | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
Remuneration paid in stock | --5.12K | --25.6K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Other non cashItems | ---- | -19.09%243.86K | -349.10%-192.51K | 261.45%286.84K | -12.57%63.55K | 19.32%85.99K | -8.86%301.39K | -49.74%77.28K | 113.32%79.36K | 5.37%72.69K |
Change In working capital | -68.80%63.42K | -263.26%-1.19M | -693.35%-1.72M | -63.68%89.68K | 120.39%237.48K | 144.09%203.29K | 184.17%727.55K | 382.96%289.58K | -8.67%246.93K | 73.99%107.75K |
-Change in receivables | --0 | -157.74%-169.24K | -201.41%-164.37K | -104.07%-3.18K | -74.30%29.37K | 49.30%-31.07K | 135.43%293.08K | 274.80%162.08K | -52.38%77.99K | 18.66%114.29K |
-Change in inventory | --0 | 762.13%80.55K | --0 | --0 | 4,316.08%51.36K | 220.35%29.19K | 109.73%9.34K | 128.16%3.4K | 75.24%-4.33K | 102.31%1.16K |
-Change in prepaid assets | --32.19K | -861.67%-41.71K | ---28.42K | 466.79%4.87K | -633.72%-18.16K | --0 | 379.53%5.48K | --0 | 86.18%-1.33K | 37.12%3.4K |
-Change in payables and accrued expense | -84.78%31.23K | -368.28%-1.02M | -1,879.72%-1.48M | -49.61%87.98K | 1,675.88%174.91K | 55.37%205.16K | 65.09%378.97K | 8,808.35%83.43K | 30.64%174.6K | -182.37%-11.1K |
-Change in other working capital | ---- | -200.00%-40.68K | ---- | ---- | ---- | ---- | --40.68K | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -238.87%-325.31K | -199.91%-1.17M | -546.66%-1.51M | -103.69%-8.26K | -69.48%114.3K | 0.97%234.25K | 118.95%1.17M | 186.60%337.38K | -21.18%223.75K | 164.81%374.55K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 603.97%3.98M | 709.94%1.46M | 4,344.92%2.66M | 85.27%-31K | 59.54%-112.14K | -127.74%-789.33K | -192.86%-238.99K | 63.67%-62.74K | -426.82%-210.46K |
Net PPE purchase and sale | --0 | -589.57%-231.95K | -117.16%-88.81K | 57.85%-191.5K | 908.91%53.01K | 94.85%-4.66K | 78.56%-33.64K | 17.60%517.62K | -9.15%-454.28K | 91.36%-6.55K |
Net investment purchase and sale | ---- | 288,212.55%2.66M | --2.66M | ---- | ---- | ---- | --924 | --0 | ---- | ---- |
Net other investing changes | ---- | 304.32%1.55M | ---1.12M | --2.85M | 58.80%-84.01K | 42.43%-107.49K | -298.89%-756.61K | ---- | ---- | -49.27%-203.9K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | 603.97%3.98M | 709.94%1.46M | 4,344.92%2.66M | 85.27%-31K | 59.54%-112.14K | -127.74%-789.33K | -192.86%-238.99K | 63.67%-62.74K | -426.82%-210.46K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 558.19%474.41K | -402.34%-2.03M | -1,575.63%-1.79M | 81.18%-41.3K | 26.87%-102.76K | -268.00%-103.54K | -42.07%-404.88K | -191.51%-106.6K | -76.84%-219.39K | 2.23%-140.53K |
Net issuance payments of debt | --0 | -1,031.96%-1.83M | -3,891.89%-1.71M | 73.25%-41.3K | 58.39%-33.57K | -130.74%-35.89K | -133.78%-161.29K | -125.40%-42.96K | -122.46%-154.39K | 9.86%-80.68K |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Interest paid (cash flow from financing activities) | --0 | 14.56%-208.12K | -12.00%-71.28K | --0 | -15.62%-69.19K | -22.77%-67.66K | -12.77%-243.59K | -20.83%-63.64K | -18.92%-65K | -10.35%-59.84K |
Net other financing activities | --474.41K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 558.19%474.41K | -402.34%-2.03M | -1,575.63%-1.79M | 81.18%-41.3K | 26.87%-102.76K | -268.00%-103.54K | -42.07%-404.88K | -191.51%-106.6K | -76.84%-219.39K | 2.23%-140.53K |
Net cash flow | ||||||||||
Beginning cash position | 21,637.38%781.02K | -88.07%3.59K | 22,058.88%2.62M | -96.17%2.69K | -52.47%22.16K | -88.07%3.59K | -76.54%30.12K | -74.24%11.81K | 19.55%70.19K | -53.82%46.62K |
Current changes in cash | 702.98%149.11K | 3,030.38%777.43K | -22,243.24%-1.84M | 4,577.19%2.61M | -182.62%-19.47K | 12.54%18.57K | 73.01%-26.53K | 47.75%-8.22K | -353.76%-58.38K | 155.79%23.57K |
End cash Position | 4,096.95%930.13K | 21,637.38%781.02K | 21,637.38%781.02K | 22,058.88%2.62M | -96.17%2.69K | -52.47%22.16K | -88.07%3.59K | -88.07%3.59K | -74.24%11.81K | 19.55%70.19K |
Free cash from | -241.69%-325.31K | -235.47%-1.4M | -301.07%-1.54M | 18.28%-199.76K | -68.94%114.3K | 62.17%229.6K | 174.29%1.03M | 1,417.81%767.27K | -84.72%-244.43K | 461.07%367.99K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data